Bruno Valentin Sinn
0000-0002-1257-9799
Charité - Universitätsmedizin Berlin
5 papers found
Refreshing results…
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial
Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer
TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
Missing publications? Search for publications with a matching author name.